Centre Hospitalier Cholet

Cholet 49325

0 studies enrolling now · 2 studies all time

What they study most

Atrial Fibrillation, Estrogen Receptor Positive Breast Cancer, HER-2 Positive Breast Cancer, Prevention of Stroke or Systemic Embolism

Studies at this site

• Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer — Running, not enrolling
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early